Monday, June 23, 2025 1:01:02 PM
There seems to be some sort of thing around 15k as CEO and two board members have about 15k each. Mitchell, Lyons, & Moyes still need to purchase their shares if they are going to.
Same question as Peeteman, What are your thoughts on the various connections? Dr Higgins being on Ned Medicals Board, Zimmer Biomet's Arthur Higgins being an advisor to ADIA, ADIA being a major investor in TVM Capital, & Sintx board member Robert Mitchell being an advisor to TVM? Not to mention Mr Lyons who just got done selling a company to Zimmer Biomet last year. accelerate commercialization and unlock the full value of its intellectual property portfolio
The moment i saw that an advisor to TVM had joined Sintx board i speculated their future investment in Sintx. So i find the above interesting.
Do they continue to pass or have they just been waiting? Zimmer & Biomet have been behind the curtain for 20 years for some reason. Why they will not make their partnership with Sintx public knowledge is something i have never understood but it could be tied, in part, to what i say next.
Your premise that because something hasnt happened it will never is flawed. For one thing pre-IPO investors obviously needed to return before something could happen. Now that a few have, management is buying shares after a decade of not really doing so. Sintx is even repurchasing shares. Lastly, they have said they intend to unlock the full value of Sintx IP. To do that they must take those various strategic partnerships to the next level.
https://www.globenewswire.com/news-release/2025/06/12/3098395/30038/en/SINTX-Technologies-Announces-Strategic-Vision-Focused-on-Expansion-Across-Key-Sectors.html
Atlanta, ive speculated that their buys are gestures to show confidence but more to help cover the cost of exercising their options in the future. Theyve already issued over 100k (about 1/3rd) of their allotment. Sintx actually utilizing their stock buyback program is a bigger deal to improve EPS and shareholders ownership percentage.
https://investorshub.advfn.com/Bostons-research-43724
Could it be that there is a strategy to distract people away from looking at basic data?
Is it an exercise to create forum verbiage to drown out any serious discussion of evidence?
Recent SINT News
- SINTX Technologies to Present at the LD Micro Invitational XVI Conference • Newsfile • 05/17/2026 07:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2026 09:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/14/2026 12:30:10 PM
- SINTX Technologies Provides Corporate Business Update Highlighting First Human Implant, Strategic Transformation, and Commercial Execution • GlobeNewswire Inc. • 03/23/2026 01:15:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/20/2026 09:00:53 PM
- SINTX Technologies Announces First-In-Human Surgery Using FDA-Cleared SINAPTIC® Foot & Ankle Implant • GlobeNewswire Inc. • 03/19/2026 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 01:02:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/10/2026 01:00:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/19/2026 02:00:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/18/2026 01:35:38 PM
- SINTX Technologies Appoints Ryan Elmore President to Lead Channel Expansion of Silicon Nitride Biomaterial Platforms • GlobeNewswire Inc. • 02/18/2026 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/11/2026 01:45:54 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/11/2026 01:44:43 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/11/2026 01:43:48 AM
- SINTX Technologies to Participate in Noble Capital Markets’ Emerging Growth Virtual Equity Conference on February 4–5 • GlobeNewswire Inc. • 01/29/2026 02:00:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/12/2025 05:15:20 AM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 12/09/2025 10:01:07 PM
- Sidoti Events, LLC's Year-End Virtual Investor Conference • ACCESS Newswire • 12/09/2025 05:48:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/09/2025 01:00:05 PM
- SINTX Technologies to Participate in Sidoti & Company Investor Conference • GlobeNewswire Inc. • 12/08/2025 02:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/08/2025 01:00:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/01/2025 01:35:26 PM
- SINTX Technologies Signs Supply Agreement with EVONIK to Manufacture Silicon Nitride–PEEK Compound for AI-Assisted, 3D-Printed Patient-Specific Implants • GlobeNewswire Inc. • 12/01/2025 01:30:00 PM
